SLC25A24 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.651000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.045800E-01
Normal-vs-Stage2
8.793200E-01
Normal-vs-Stage3
1.286590E-01
Normal-vs-Stage4
2.684600E-01
Stage1-vs-Stage2
5.348200E-01
Stage1-vs-Stage3
3.259600E-01
Stage1-vs-Stage4
1.151020E-01
Stage2-vs-Stage3
8.862400E-02
Stage2-vs-Stage4
2.502000E-01
Stage3-vs-Stage4
6.950400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.746200E-01
Normal-vs-AfricanAmerican
6.793800E-01
Normal-vs-Asian
8.853200E-01
Caucasian-vs-AfricanAmerican
4.147000E-01
Caucasian-vs-Asian
7.162600E-01
AfricanAmerican-vs-Asian
6.908600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.070000E-01
Normal-vs-Female
8.364600E-01
Male-vs-Female
2.009000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.690800E-01
Normal-vs-Age(41-60Yrs)
6.562000E-01
Normal-vs-Age(61-80Yrs)
8.683800E-01
Normal-vs-Age(81-100Yrs)
8.336000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.253600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.968400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.249600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.351700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.432600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.549000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.884200E-01
Normal-vs-Daily Drinker
9.194400E-01
Normal-vs-Weekly Drinker
4.258000E-01
Normal-vs-Occasional Drinker
5.941200E-01
Normal-vs-Social Drinker
8.582000E-01
Non Drinker-vs-Daily Drinker
8.737800E-01
Non Drinker-vs-Weekly Drinker
3.029200E-01
Non Drinker-vs-Occasional Drinker
8.259700E-02
Non Drinker-vs-Social Drinker
9.209800E-01
Daily Drinker-vs-Weekly Drinker
4.130600E-01
Daily Drinker-vs-Occasional Drinker
2.516600E-01
Daily Drinker-vs-Social Drinker
9.522200E-01
Weekly Drinker-vs-Occasional Drinker
4.121800E-02
Weekly Drinker-vs-Social Drinker
3.629600E-01
Occasional Drinker-vs-Social Drinker
2.055600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.856800E-01
Normal-vs-Grade 2
5.380200E-02
Normal-vs-Grade 3
1.901880E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.219610E-02
Grade 1-vs-Grade 3
8.922300E-03
Grade 1-vs-Grade 4
2.856800E-01
Grade 2-vs-Grade 3
8.197400E-01
Grade 2-vs-Grade 4
5.380200E-02
Grade 3-vs-Grade 4
1.901880E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.885800E-01
Normal-vs-NonDiabetic
9.923600E-01
Diabetic-vs-NonDiabetic
1.788780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.365000E-01
Normal-vs-NoPancreatitis
9.621800E-01
Pancreatitis-vs-NoPancreatitis
7.798000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.585000E-01
Normal-vs-N1
8.521800E-01
N0-vs-N1
2.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.852600E-01
Normal-vs-TP53-NonMutant
6.974400E-01
TP53-Mutant-vs-TP53-NonMutant
3.552700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
